Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence

High Blood Press Cardiovasc Prev. 2024 Mar;31(2):157-166. doi: 10.1007/s40292-024-00632-6. Epub 2024 Mar 26.

Abstract

Introduction: Cardiac organ damage like left ventricular (LV) hypertrophy and left atrial (LA) enlargement is more prevalent in women than men with hypertension, but the mechanisms underlying this gender difference remain unclear.

Methods: We tested the association of drug nonadherence with the presence of LV hypertrophy and LA enlargement by echocardiography in 186 women and 337 men with uncontrolled hypertension defined as daytime systolic blood pressure (BP) ≥ 135mmHg despite the prescription of at least two antihypertensive drugs. Drug adherence was assessed by measurements of serum drug concentrations interpreted by an experienced pharmacologist. Aldosterone-renin-ratio (ARR) was measured on actual medication.

Results: Women had a higher prevalence of LV hypertrophy (46% vs. 33%) and LA enlargement (79% vs 65%, both p < 0.05) than men, while drug nonadherence (8% vs. 9%, p > 0.514) did not differ. Women were older and had lower serum renin concentration and higher ARR than men, while 24-h systolic BP (141 ± 9 mmHg vs. 142 ± 9 mmHg), and the prevalences of obesity (43% vs. 50%) did not differ (all p > 0.10). In multivariable analyses, female gender was independently associated with a two-fold increased risk of LV hypertrophy (OR 2.01[95% CI 1.30-3.10], p = 0.002) and LA enlargement (OR 1.90 [95% CI 1.17-3.10], p = 0.010), while no association with drug nonadherence was found. Higher ARR was independently associated with LV hypertrophy in men only (OR 2.12 [95% CI 1.12-4.00] p = 0.02).

Conclusions: Among patients with uncontrolled hypertension, the higher prevalence of LV hypertrophy and LA enlargement in women was not explained by differences in drug nonadherence.

Registration: URL: https://www.

Clinicaltrials: gov ; Unique identifier: NCT03209154.

Keywords: Aldostero-Renin Ratio; Cardiac organ damage; Drug adherence; Gender; Left atrial enlargement; Left ventricular hypertrophy; Obesity; Primary aldosteronism; Sex; Uncontrolled hypertension.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aldosterone / blood
  • Antihypertensive Agents* / therapeutic use
  • Arterial Pressure / drug effects
  • Atrial Function, Left / drug effects
  • Atrial Remodeling / drug effects
  • Biomarkers / blood
  • Cross-Sectional Studies
  • Female
  • Health Status Disparities
  • Humans
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Hypertension* / physiopathology
  • Hypertrophy, Left Ventricular* / diagnostic imaging
  • Hypertrophy, Left Ventricular* / epidemiology
  • Hypertrophy, Left Ventricular* / physiopathology
  • Male
  • Medication Adherence*
  • Middle Aged
  • Prevalence
  • Renin* / blood
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Treatment Outcome
  • Ventricular Function, Left / drug effects
  • Ventricular Remodeling / drug effects

Substances

  • Aldosterone
  • Antihypertensive Agents
  • Biomarkers
  • Renin

Associated data

  • ClinicalTrials.gov/NCT03209154